Finance

Lists
Why is TNYA down 25.05%?
Dive Deeper
TNYA:NASDAQ
Tenaya Therapeutics Inc
$ 0.39
-25.05%
(-0.13) 1D
$ 0.41
+4.97% (+0.019)
After hours
Closed: 10-р сарын 14, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TNYA...
Open
$ 0.50
High
$ 0.51
Low
$ 0.36
Mkt. cap
87.73 сая
Avg. vol.
2.73 сая
Volume
18.15 сая
52-wk high
$ 2.04
52-wk low
$ 0.36
EPS
-$ 0.53
Beta
2.87
Shares outstanding
224.23 сая
No. of employees
70
Open
$ 0.50
High
$ 0.51
Low
$ 0.36
Mkt. cap
87.73 сая
Avg. vol.
2.73 сая
Volume
18.15 сая
52-wk high
$ 2.04
52-wk low
$ 0.36
EPS
-$ 0.53
Beta
2.87
Shares outstanding
224.23 сая
No. of employees
70
News stories
From web sources and news partners
About Tenaya Therapeutics Inc
CEO-
Employees70
Founded2016
HeadquartersSouth San Francisco, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to TNYA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for TNYA in the last 3 months.
Highest
Current $ 0.39
$ 40.00 (+10,143.28%)
Average
$ 13.00 (+3,229.07%)
Lowest
$ 3.00 (+668.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$ 3.00
+668.2%
10/05/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$ 5.00
+1,180.4%
08/06/2026
Cory Jubinville, PhD
LifeSci Capital
Buy
Maintained
$ 4.00
+924.3%
08/06/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$ 40.00
+10,143.3%
08/06/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
08/06/2026
Andy Hsieh
William Blair
Buy
Maintained
-
-
07/29/2026
Michael Ulz
Morgan Stanley
Buy
Reiterated
$ 2.00
+412.2%
06/03/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$ 8.00
+1,948.7%
05/15/2026
Last report
2026 оны 8-р сарын 5
Fiscal period
Q2 2026
-$ 0.09 / -$ 0.07
-35.90%miss
Revenue / Est. (USD)
1.11 сая / 10.00 сая
-88.90%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
-
-
225.00 мян
1.11 сая
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.36 сая
14.80 сая
14.84 сая
16.60 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.57 сая
5.98 сая
5.45 сая
5.41 сая
Operating expense
20.94 сая
20.78 сая
20.29 сая
22.01 сая
Total operating expenses
20.94 сая
20.78 сая
20.29 сая
22.01 сая
Operating income
-20.94 сая
-20.78 сая
-20.06 сая
-20.90 сая
Other non operating income
3.00 мян
25.00 мян
-
-1.37 сая
EBT including unusual items
-20.28 сая
-20.18 сая
-19.27 сая
-43.39 сая
EBT excluding unusual items
-20.28 сая
-20.18 сая
-19.27 сая
-21.57 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.28 сая
-20.18 сая
-19.27 сая
-43.39 сая
Net profit margin
-
-
-8,565.33%
-3,909.28%
Earnings per share
-0.12
-0.12
-0.09
-0.09
Interest and investment income
658.00 мян
575.00 мян
793.00 мян
697.00 мян
Interest expense
-
-
-
-
Net interest expenses
658.00 мян
575.00 мян
793.00 мян
697.00 мян
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.07 сая
-18.95 сая
-18.30 сая
-19.20 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс